Abstract
Bone tumors are a rare kind of neoplasm. Their varied clinical manifestations, together with their rarity of occurrence, involve the pathologist in considerable difficulties in differentiating benign or merely reactive changes from malignant disease. Correct diagnosis of bone tumors calls for close interdisciplinary Cooperation, but even then the difficulties may be grave, and sometimes hardly surmountable in differential diagnosis. Further improvement in the prognosis of malignant osseous neoplasm — beyond the progress seen in recent years — will be achieved only by earlier recognition and greater diagnostic accuracy. Any diagnostic considerations should therefore be centered upon the recognition of the tumor type and its biological behavior.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Auböck L (1975) Zur Ultrastruktur fibröser und histiocytärer Hauttumoren (Dermatofibroma, Dermatofibrosarcoma protuberans, Fibroxanthom and Histiocytom). Virchows Archiv 368: 253–274
Bouropoulou V, Kontogeorgos G, Papamichales G, Bosse A, Roessner A, Vollmer E (1987) Differential diagnosis of chordoma. Immunohistochemical aspects. Arch Anat Cytol Pathol 35: 35–40
Dahlin DC, Unni KK (1986) Bone tumors. General aspects and data on 8542 cases, 3rd edn. Charles C. Thomas, Springfield
Dahlin DC, Cupps RE, Johnson EW Jr (1970) Giant cell tumors: a study of 195 cases. Cancer 25: 1061–1070
Dahlin DC, Unni KK (1977) Osteosarcoma of bone and its important recognizable varieties. Am J Surg Pathol 1: 61–72
Dominok GW, Knoch HG (1982) Knochengeschwülste und geschwulstähnliche Knochenerkrankungen, 3rd edn. VEB Gustav Fischer, Jena
Gerdes J (1985) An immunohistological method for estimating cell growth fractions in rapid histopathological diagnosis during surgery. Int J Cancer 35: 169–171
Gerdes J, Schwab U, Lembke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13–20
Gerdes J, Lembke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710–1715
Gerdes J, Pileri S, Bartels H, Stein H (1986) Proliferation marker Ki-67: correlation with histological diagnosis, histological tumor grading, and prognosis. Verh Dtsch Ges Pathol 70: 152–158
Grundmann E (ed) (1976) Malignant bone tumors. Springer, Berlin Heidelberg New York (Rec Res Cancer Res, vol 54)
Grundmann E, Mellin W, Roessner A, Bösing Th, Hiddemann W, Vollmer E, Edel G, Lingg G (1986) Zur Klassification und Prognose der Osteosarkome im Erfahrungsgut des Knochengeschwulstregisters Westfalen unter Einbezug proliferationskinetischer Parameter. In: Dietsch P, Keck E, Kruse HP, Kuhlencordt F (eds) Aktuelle Ergebnisse der Osteologie. W. de Gruyter, Berlin, pp 221–226
Heliö H, Karaharju E, Nordling S (1985) Flow cytometric determination of DNA content in malignant and benign bone tumors. Cytometry 6: 165–171
Huvos AG (1979) Bone tumors: diagnosis, treatment and prognosis. W.S. Saunders, Philadelphia
Jaffe HL, Lichtenstein L, Portis RB (1940) Giant cell tumor of bone. Its pathologic appearance, grading, supposed variants and treatment. Arch Pathol. 30: 993–1031
Jaffe HL (1958) Tumors and tumorous conditions of the bones and joints. Lea amp Febiger, Philadelphia
Kertelge E, Roessner A, Vollmer E, Winterberg B, Tenschert W, Vetter H, Hauss J, Buchholz B (1987) Immunohistological evaluation of 36 pheochromocytomas with regard to Proteohormone secretion and proliferation. Arch Anat Cytol Pathol 35: 155–161
Kreicbergs A, Tribukat B (1984) Flow DNA analysis of primary bone tumors. Relationship between cellular DNA content and histopathologic Classification. Cancer 53: 129–136
Lichtenstein L (1977) Bone tumors, 4th edn. C. V. Mosby, St. Louis
Matsuno T, Unni KK, McLeod RA, Dahlin DC (1976) Telangiectatic osteogenic sarcoma. Cancer 38: 2538–2547
Miettinen M, Letho CP, Virtanen I (1983) Differential diagnosis of chordoma, chondroid, and ependymal tumors as aided by anti-intermediate Filament antibody. Am J Pathol 112: 160–169
Roessner A (1984) Zur Zyto- und Histogenese der malignen und semimalignen Knochentumoren. Veröffentlichungen aus der Pathologie, H. 122. Gustav Fischer, Stuttgart
Roessner A, Hobik HP, Grundmann E (1979) Malignant fibrous histiocytoma of bone and osteosarcoma. A comparative light and electron microscopy study. Path. Res. Pract. 164: 385–401
Roessner A, Immenkamp M, Weidner A, Hobik HP, Grundmann E (1981) Benign fibrous histiocytoma of bone. Light and electron microscopic Observation. J Cancer Res Clin Oncol 101: 191–202
Roessner A, Mellin W, Hiddemann W, Voss B, Vollmer E, Grundmann E (1984a) New cytomorphologic methods in the diagnosis of bone tumors: possibilities and limitations. Semin Diagn Pathol 13: 199–214
Roessner A, v. Bassewitz DB, Schlake W, Thorwesten G, Grundmann E (1984b) Biological characterization of human bone tumors. III. Giant cell tumor of bone. Pathol Res Pract 178: 431–440
Roessner A, Vollmer E, Sorg C, Grundmann E (1986) Die Rolle der Makrophagen und osteoklastenähnlichen Riesenzellen in Knochentumoren. In: Dietsch P, Keck E, Kruse HP, Kuhlencordt F (eds) Aktuelle Ergebnisse der Osteologie. W. de Gruyter, Berlin, pp 227–232
Roessner A, Vassallo J, Vollmer E, Zwadlo G, Sorg C, Grundmann E (1987) Biological characterization of human bone tumors. X. The proliferation behavior of macrophages as compared to fibroblastic cells in malignant flbrous hastioeytoma and giant cell tumor of bone. J Cancer Res Clin Oncol 113: 559–562
Rosen G, Caparros B, Huvos AG, Kosloff C, Nierenberg A, Cacavio A, Marcove RC, Labe JM, Metha B, Urban C (1982) Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49: 1221–1230
Schajowicz F (1981) Tumors änd tumorlike lesions of the bones and joints. Springer, New York
Schajowicz F, Ackerman LV, Sissons HA, Sobin LH, Torloni H (1972) Histological typing of bone tumours. International Classification of Tumours, vol 6. WHO, Geneva
Spanier SS (1977) Malignant fibrous histiocytoma of bone. Orthop Clin North Am 8: 947–961
Spjut HJ, Dorfman HD, Fechner RE, Ackerman LV (1971) Tumors of Bone and Cartilage. AF Atlas of Tumor Pathology II/5 AF Inst of Pathology, Washington/DC
Unni KK, Dahlin DC (1984) Grading of bone tumors. Semin Diagn Pathol 13: 165–172
Unni KK, Dahlin DC, McLeod RA, Pritchard DJ (1977) Intraosseous well-differentiated osteosarcoma. Cancer 40: 1337–1347
Vollmer E, Bouropoulou V, Roessner A, Erwig H, Grundmann E (1985) Immunohistologische und elektronenmikroskopische Untersuchungen an Chordomen. Verh Dtsch Ges Pathol 69: 633
Vollmer E, Roessner A, Lipecki KH, Zwadlo G, Hagemeier HH, Grundmann E (1987) Biologie characterization of human bone tumors. VI. The aneurysmal bone cyst: an enzyme histochemical, electron microscopical, and immunohistological study. Virchows Archiv 53: 58–65
Weibel ER, Elias H (1967) Quantitative methods in morphology. Springer, Berlin Heidelberg New York
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Vollmer, E., Roessner, A., Wuisman, P., Härle, A., Grundmann, E. (1989). The Proliferation Behavior of Bone Tumors Investigated with the Monoclonal Antibody Ki-67. In: Roessner, A. (eds) Biological Characterization of Bone Tumors. Current Topics in Pathology, vol 80. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74462-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-74462-4_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74464-8
Online ISBN: 978-3-642-74462-4
eBook Packages: Springer Book Archive